Literature DB >> 11287748

Regulation of thymidine kinase expression during cellular senescence.

Z F Chang1, D Y Huang.   

Abstract

As human diploid fibroblasts (HDFs) in culture senesce, the expression of thymidine kinase (TK) and the activity of its promoter become attenuated. Herein we analyze the cis-elements involved in transcriptional activation of the hTK promoter, and show that the Sp1 binding site located at -118/-113 and one CCAAT box located at either -71/-67 or -40/-36 are critical for maximal expression of hTK promoter activity in young IMR-90 HDFs. However, the DNA binding activities to TK-CCAAT and Sp1 were not defective in serum-stimulated senescent HDFs. On the other hand, treatment of young HDFs during the late G1 transition with a specific inhibitor of CDK2, roscovitine, blocked the induction of TK RNA expression. Because CDK2 remained inactive during serum stimulation in senescent HDFs, it is likely that the impairment of TK expression in senescent HDFs during serum stimulation is relevant to the inactivation of CDK2, rather than to the controlling mechanism at the level of NF-Y and Sp1 activity. Copyright 2001 National Science Council, ROC and S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287748     DOI: 10.1159/000054030

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  3 in total

1.  Specific inhibition of NF-Y subunits triggers different cell proliferation defects.

Authors:  Paolo Benatti; Diletta Dolfini; Alessandra Viganò; Maria Ravo; Alessandro Weisz; Carol Imbriano
Journal:  Nucleic Acids Res       Date:  2011-03-16       Impact factor: 16.971

2.  Antifibrotic effects of roscovitine in normal and scleroderma fibroblasts.

Authors:  Richard A Steinman; Andria Rasile Robinson; Carol A Feghali-Bostwick
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

3.  Conserved Senescence Associated Genes and Pathways in Primary Human Fibroblasts Detected by RNA-Seq.

Authors:  S Marthandan; M Baumgart; S Priebe; M Groth; J Schaer; C Kaether; R Guthke; A Cellerino; M Platzer; S Diekmann; P Hemmerich
Journal:  PLoS One       Date:  2016-05-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.